2027 SPEAKERS

Ana Filipa Alexandre, GHEVO, Neuroscience Pipeline Head, Teva Pharmaceuticals

Ana Filipa Alexandre | GHEVO, Neuroscience Pipeline Head | Teva Pharmaceuticals » speaking at World EPA Congress

Eunice Alvazzi, Global Head, Hematology, Nephrology, Transplant & Neurology, Access & Pricing, Alexion Pharmaceuticals, Inc.

Eunice Alvazzi | Global Head, Hematology, Nephrology, Transplant & Neurology, Access & Pricing | Alexion Pharmaceuticals, Inc. » speaking at World EPA Congress

Georges André, President, Institut Français Valeur en Santé

Michael Andreou, Value & Access Lead, Rare Diseases, Biogen, Biogen

Ad Antonisse, Director, Market Access & Corporate Affairs, AstraZeneca

Jorge Arellano, Senior Vice President, Global Head PAVE, Pricing, Access, Value & Evidence, BioMarin

Jorge Arellano | Senior Vice President, Global Head PAVE, Pricing, Access, Value & Evidence | BioMarin » speaking at World EPA Congress

Gordon Bache, Partner, Windrose Consulting Group

Teresa Barcina Lacosta, Manager, HTA, MedTech Europe

Teresa Barcina Lacosta | Manager, HTA | MedTech Europe » speaking at World EPA Congress

Fabienne Bartoli, Inspector General, French National Authority for Health

Fabienne Bartoli | Inspector General | French National Authority for Health » speaking at World EPA Congress

Alex Bastian, Vice President, Commercial Strategy, Memo Therapeutics

Stefano Benvenuti, Head of Public Affairs and Market Access, fondazione telethon

Stefano Benvenuti | Head of Public Affairs and Market Access | fondazione telethon » speaking at World EPA Congress

Tomer Benzaken, Head of Commercial Operations & Trade, Astellas

Tomer Benzaken | Head of Commercial Operations & Trade | Astellas » speaking at World EPA Congress

Rimma Berenstein, Deputy Head, Pharmaceuticals Department, G-BA

Rimma Berenstein | Deputy Head, Pharmaceuticals Department | G-BA » speaking at World EPA Congress

Katja Berg, Global Senior Pricing and Market Access Director, Infectious Diseases, BBU, AstraZeneca

Ingrid Bettum, Senior Adviser, Unit for HTA Cancer Medicines, Norwegian Medicines Agency

Ingrid Bettum | Senior Adviser, Unit for HTA Cancer Medicines | Norwegian Medicines Agency » speaking at World EPA Congress

Thomas Bols, Head of Government Affairs and Patient Advocacy, EMEA & APAC, PTC Therapeutics

Thomas Bols | Head of Government Affairs and Patient Advocacy, EMEA & APAC | PTC Therapeutics » speaking at World EPA Congress

Pedro Borga, Global Pricing Director, BioMarin Pharmaceutical Inc.

Pedro Borga | Global Pricing Director | BioMarin Pharmaceutical Inc. » speaking at World EPA Congress

Stefan Bos, Independent Patient Expert and Speaker, Stefan Bos Consulting

Okke-Jaap Bosgra, Director International Market Access, Natera

Okke-Jaap Bosgra | Director International Market Access | Natera » speaking at World EPA Congress

Eric Bouteiller, Author & Adjunct Professor, China Europe International Business School (CEIBS)

Eric Bouteiller | Author & Adjunct Professor | China Europe International Business School (CEIBS) » speaking at World EPA Congress

Vidya Breeveld, founder & CEO, Transmineo

Vidya Breeveld | founder & CEO | Transmineo » speaking at World EPA Congress

Niall Brennan, Chief Data and Analytics Officer, Blue Cross Blue Shield of New Jersey

Niall Brennan | Chief Data and Analytics Officer | Blue Cross Blue Shield of New Jersey » speaking at World EPA Congress

Thomas Broekhoff, Program Manager Medicines, hollandbio

Thomas Broekhoff | Program Manager Medicines | hollandbio » speaking at World EPA Congress

Henriette Burghoorn, Associate Director, Market Access, Gilead Sciences

Henriette Burghoorn | Associate Director, Market Access | Gilead Sciences » speaking at World EPA Congress

Lorenzo Capretto, Head of HTA Strategy and Pricing, Global Rare Disease, Chiesi Farmaceutici Spa

Lorenzo Capretto | Head of HTA Strategy and Pricing, Global Rare Disease | Chiesi Farmaceutici Spa » speaking at World EPA Congress

Antonella Cardone, CEO, Cancer Patients Europe

Antonella Cardone | CEO | Cancer Patients Europe » speaking at World EPA Congress

David Catterick, Co-founder and Director, Catterick Consulting Ltd

David Catterick | Co-founder and Director | Catterick Consulting Ltd » speaking at World EPA Congress

Lamis Chahoud, Head of Access & Pricing Region New Markets, BeOne Medicines

Lamis Chahoud | Head of Access & Pricing Region New Markets | BeOne Medicines » speaking at World EPA Congress

Bruno Cherel, Senior Director, Head of Pricing, Jazz Pharmaceuticals

Bruno Cherel | Senior Director, Head of Pricing | Jazz Pharmaceuticals » speaking at World EPA Congress

Jag Chhatwal, Director, Center for Health Technology Assessment, Harvard Medical School

José Luis Sánchez Chorro, Director, Market Access, Public Affairs, Tenders and Supply, ADVANZ PHARMA

José Luis Sánchez Chorro | Director, Market Access, Public Affairs, Tenders and Supply | ADVANZ PHARMA » speaking at World EPA Congress

Sally Chung, Vice President, Global Value & Access International Operations & Excellence, Ipsen

Graham Cookson, CEO, Office of Health Economics

Marie-Monique de Molliens, Global Market Access Horizon Scanning Senior Director, Sanofi

Marie-Monique de Molliens | Global Market Access Horizon Scanning Senior Director | Sanofi » speaking at World EPA Congress

Rossella Di Bidino, Head of HTA for AI Unit, Graduate School of Health Economics and Management ALTEMS

Rossella Di Bidino | Head of HTA for AI Unit | Graduate School of Health Economics and Management ALTEMS » speaking at World EPA Congress

Jose Diaz, Global Health Systems Economics & Value of Innovation, BMS

Jose Diaz | Global Health Systems Economics & Value of Innovation | BMS » speaking at World EPA Congress

Eva Susanne Dietrich, Professor, Departments for Clinical Pharmacy and Regulatory Affairs, University of Bonn

Toon Digneffe, Head Public Affairs & Public Policy, Takeda

Delphine Dioudonnat, Executive Director Global Head of Pricing & Biosimilars Market Access, Organon

Delphine Dioudonnat | Executive Director Global Head of Pricing & Biosimilars Market Access | Organon » speaking at World EPA Congress

Riad Dirani, Vice President, Global Health Economics, Value and Outcomes, Teva Pharmaceuticals

Riad Dirani | Vice President, Global Health Economics, Value and Outcomes | Teva Pharmaceuticals » speaking at World EPA Congress

Maurice Driessen, Senior Director, Head of Inline Brands, GHEVO, Teva Pharmaceuticals

Maurice Driessen | Senior Director, Head of Inline Brands, GHEVO | Teva Pharmaceuticals » speaking at World EPA Congress

Marcus Droege, Executive Vice President, Managing Director, Pharmaconcepts

Marcus Droege | Executive Vice President, Managing Director | Pharmaconcepts » speaking at World EPA Congress

Marieangela Economopoulou, Head of Access & External Affairs SEE Region, UCB

Karen Facey, Senior HTA Advisor, University of Edinburgh

Stefaan Fiers, Chapter Head, External Affairs, Roche

Stefaan Fiers | Chapter Head, External Affairs | Roche » speaking at World EPA Congress

Steven Flostrand, Executive Director, Value, Access & Pricing, Incyte Corp.

Steven Flostrand | Executive Director, Value, Access & Pricing | Incyte Corp. » speaking at World EPA Congress

Katie Gardner, Global Head of Market Access Excellence & Capabilities, Astellas

Katie Gardner | Global Head of Market Access Excellence & Capabilities | Astellas » speaking at World EPA Congress

Ramiro Gilardino, Associate Professor of Public Health, Buenos Aires School of Public Health

Ramiro Gilardino | Associate Professor of Public Health | Buenos Aires School of Public Health » speaking at World EPA Congress

Frédéric Girard, President, France Biotech

Frédéric Girard | President | France Biotech » speaking at World EPA Congress

Christoph Glaetzer, Chief Global Value and Access Officer, Johnson & Johnson Innovative Medicine

Christoph Glaetzer | Chief Global Value and Access Officer | Johnson & Johnson Innovative Medicine » speaking at World EPA Congress

Aveline Godard, Head of Global Pricing & Tendering, Ferring

Aveline Godard | Head of Global Pricing & Tendering | Ferring » speaking at World EPA Congress

Enric Gomez, Director Strategy, Pricing & Analytics, Merck Group

Enric Gomez | Director Strategy, Pricing & Analytics | Merck Group » speaking at World EPA Congress

Adam Gordois, Director, Value Demonstration & HEOR, BioCryst Pharmaceuticals

Adam Gordois | Director, Value Demonstration & HEOR | BioCryst Pharmaceuticals » speaking at World EPA Congress

Alexander Grosvenor, Senior Vice President, Managing Director, Precision Value & Health

Alexander Grosvenor | Senior Vice President, Managing Director | Precision Value & Health » speaking at World EPA Congress

Brad Groves, Director, NICE Advice, National Institute for Health & Care Excellence (NICE)

Thomas Grub, Director, Global Pricing and Market Access, Medac GmbH

Thomas Grub | Director, Global Pricing and Market Access | Medac GmbH » speaking at World EPA Congress

Neil Grubert, Global Market Access Expert, Independent

Neil Grubert | Global Market Access Expert | Independent » speaking at World EPA Congress

Marlene Gyldmark, EU HTA lead, BeOne Medicines

Marlene Gyldmark | EU HTA lead | BeOne Medicines » speaking at World EPA Congress

Luis Hernandez, VP, Head of Evidence Generation, Oncology, Takeda

Karla Hernandez-Villafuerte, Health Economics Research and Innovation Strategy Lead, WifOR

Karla Hernandez-Villafuerte | Health Economics Research and Innovation Strategy Lead | WifOR » speaking at World EPA Congress

Patrick Hopkinson, Independent HTA Expert, Independent HTA Expert

Patrick Hopkinson | Independent HTA Expert | Independent HTA Expert » speaking at World EPA Congress

Amy Israel, Senior Advisor, Access to Medicines, Union for International Cancer Control

Amy Israel | Senior Advisor, Access to Medicines | Union for International Cancer Control » speaking at World EPA Congress

Nicolas Jamet, Global Pricing and Market Access Lead, GSK

Nicolas Jamet | Global Pricing and Market Access Lead | GSK » speaking at World EPA Congress

Sophie Janssens, Sr VP, Global Head of Patient Impact Maximization (GO), UCB

Sophie Janssens | Sr VP, Global Head of Patient Impact Maximization (GO) | UCB » speaking at World EPA Congress

Iroda Jurabekova, Executive Director, Global Market Access, Oncology, Boehringer Ingelheim

Iroda Jurabekova | Executive Director, Global Market Access, Oncology | Boehringer Ingelheim » speaking at World EPA Congress

Madhu Kabra, Global Director, HEOR, MKGlobal

Madhu Kabra | Global Director, HEOR | MKGlobal » speaking at World EPA Congress

Laurie Kan, Sr. Director, Global Market Access, CSL

Laurie Kan | Sr. Director, Global Market Access | CSL » speaking at World EPA Congress

Irem Karaomerlioglu, Health Technology Assessment Unit Supervisor, Turkish Medicines and Medical Devices Agency

Ankita Kaushik, Senior Director, HEOR, Global Value and Access, Gilead Sciences

Ankita Kaushik | Senior Director, HEOR, Global Value and Access | Gilead Sciences » speaking at World EPA Congress

Elizabeth Kinter, Vice President, Head of Global Market Access, Avidity BioSciences

Elizabeth Kinter | Vice President, Head of Global Market Access | Avidity BioSciences » speaking at World EPA Congress

Sven Klijn, Director, HEOR Evidence Acceleration & Innovation, Bristol Myers Squibb

Sven Klijn | Director, HEOR Evidence Acceleration & Innovation | Bristol Myers Squibb » speaking at World EPA Congress

Birgitte Klindt Poulsen, Chair, Danish Medicines Council

Birgitte Klindt Poulsen | Chair | Danish Medicines Council » speaking at World EPA Congress

jolanda koenders, Policy & Advocacy, takeda

jolanda koenders | Policy & Advocacy | takeda » speaking at World EPA Congress

Antti Kourula, Global Head of Market Access, CSL Behring

Antti Kourula | Global Head of Market Access | CSL Behring » speaking at World EPA Congress

Diane Lastennet, French National Authority for Health

Diane Lastennet |  | French National Authority for Health » speaking at World EPA Congress

Gavin Lewis, Senior Vice President, Head of Value and Access, Novartis

Mira Ludwikowska, Co-Chair of the JSC Subgroup, Agency for Health Technology Assessment and Tariff System

Richard Macaulay, Senior Vice President, Precision AQ

Richard Macaulay | Senior Vice President | Precision AQ » speaking at World EPA Congress

Charles Makin, Head of US Real World Evidence & Epidemiology, Boehringer Ingelheim

Charles Makin | Head of US Real World Evidence & Epidemiology | Boehringer Ingelheim » speaking at World EPA Congress

Bill Malcolm, Executive Director, Global HEOR EAI, Bristol Myers Squibb

Bill Malcolm | Executive Director, Global HEOR EAI | Bristol Myers Squibb » speaking at World EPA Congress

Marco Marchetti, Co-Chair, HTA Coordination Group & Director, Health Technology Assessment Unit, European Commission & National Agency for Regional Care Services, Italy

Marco Marchetti | Co-Chair, HTA Coordination Group & Director, Health Technology Assessment Unit | European Commission & National Agency for Regional Care Services, Italy » speaking at World EPA Congress

Silvy Mardiguian, Head of HEOR, Europe & New Markets, BeOne Medicines

Silvy Mardiguian | Head of HEOR, Europe & New Markets | BeOne Medicines » speaking at World EPA Congress

Sandra Margunato Debay, Executive Director, Global Value, Access and Pricing, Revolution Medicines

Sandra Margunato Debay | Executive Director, Global Value, Access and Pricing | Revolution Medicines » speaking at World EPA Congress

Emanuele Marsili, Global Access Lead, CSL

Emanuele Marsili | Global Access Lead | CSL » speaking at World EPA Congress

Klara Marton, International Strategic Business Development Director, Egis Pharmaceuticals Plc

Klara Marton | International Strategic Business Development Director | Egis Pharmaceuticals Plc » speaking at World EPA Congress

Simon McNamara, Senior Director, Real World Evidence, GSK

Simon McNamara | Senior Director, Real World Evidence | GSK » speaking at World EPA Congress

Vanessa Mirsky, Vice President, Life Sciences Data Strategy, RWE/RWD, OneOncology

Vanessa Mirsky | Vice President, Life Sciences Data Strategy, RWE/RWD | OneOncology » speaking at World EPA Congress

Alessandro Monaco, General Manager, Oliba Healthcare and Pharma

Alessandro Monaco | General Manager | Oliba Healthcare and Pharma » speaking at World EPA Congress

Daniel Moreira, Co-CEO & Co-Founder, Cellbyte GmbH

Daniel Moreira | Co-CEO & Co-Founder | Cellbyte GmbH » speaking at World EPA Congress

Santiago Moreno, Global Head HEOR, Menarini

Santiago Moreno | Global Head HEOR | Menarini » speaking at World EPA Congress

Paolo Morgese, Vice President, Public Affairs, Europe and Middle East, Alliance for Regenerative Medicine

Paolo Morgese | Vice President, Public Affairs, Europe and Middle East | Alliance for Regenerative Medicine » speaking at World EPA Congress

Gorden Muduma, Senior Director , Head of Market Access -EMEA Region, Orchard Therapeutics

Gorden Muduma | Senior Director , Head of Market Access -EMEA Region | Orchard Therapeutics » speaking at World EPA Congress

Michael Mueller, Head of Market Access, Western Europe, Sun Pharma

Michael Mueller | Head of Market Access, Western Europe | Sun Pharma » speaking at World EPA Congress

Thomas Müller, Head Of Directorate General 1 - Drugs, Medical Devices, Biotechnology, Federal Ministry of Health Germany

Thomas Müller | Head Of Directorate General 1 - Drugs, Medical Devices, Biotechnology | Federal Ministry of Health Germany » speaking at World EPA Congress

Alexander Natz, Secretary General, EUCOPE - European Confederation of Pharmaceutical Entrepreneurs

Alexander Natz | Secretary General | EUCOPE - European Confederation of Pharmaceutical Entrepreneurs » speaking at World EPA Congress

Anh Bourcet Nguyen, International Director, Government Affairs and Policy, Rare Diseases, AstraZeneca

Anh Bourcet Nguyen | International Director, Government Affairs and Policy, Rare Diseases | AstraZeneca » speaking at World EPA Congress

Brigitte Nolet, Head, Global Access for the Pharmaceuticals Division, Roche

Brigitte Nolet | Head, Global Access for the Pharmaceuticals Division | Roche » speaking at World EPA Congress

Melvin Skip Olson, Founder, Olson Strategies GmbH

Melvin Skip Olson | Founder | Olson Strategies GmbH » speaking at World EPA Congress

Funmi Oluwa, Head of Market Access & External Engagement, UCB Pharma

Siew Ong, Senior Director, Cytokinetics

Siew Ong | Senior Director | Cytokinetics » speaking at World EPA Congress

Dennis Ostwald, Founder & Chief Executive Officer, WifOR Institute

Gianfranco Parlato, Global Head of Value Access, Pricing & Policy CMVD (CardioMetabolism & Venous Diseases), Servier International

Gianfranco Parlato | Global Head of Value Access, Pricing & Policy CMVD (CardioMetabolism & Venous Diseases) | Servier International » speaking at World EPA Congress

Adam PARNABY, Lead, Global Policy & Access, Bristol Myers Squibb

Adam PARNABY | Lead, Global Policy & Access | Bristol Myers Squibb » speaking at World EPA Congress

Dilip Patel, SVP Global Pricing and Market Access, Autolus

Dilip Patel | SVP Global Pricing and Market Access | Autolus » speaking at World EPA Congress

Peter Pemberton-Ross, Head, HE & HTA Strategy, Biogen

Peter Pemberton-Ross | Head, HE & HTA Strategy | Biogen » speaking at World EPA Congress

Tomaso Piaggio, Head of International Market Access, Pricing & Policy, Alnylam Pharmaceuticals

Tomaso Piaggio | Head of International Market Access, Pricing & Policy | Alnylam Pharmaceuticals » speaking at World EPA Congress

Trine Pilgaard, Director, Head of Market Access, Denmark and Iceland, Pfizer

Trine Pilgaard | Director, Head of Market Access, Denmark and Iceland | Pfizer » speaking at World EPA Congress

Uffe Ploug, Global Health Economics Director, UCB

Uffe Ploug | Global Health Economics Director | UCB » speaking at World EPA Congress

Luca Luigi Polastri, Global Value and Access Head, Nephrology Franchise, Kyowa Kirin

Luca Luigi Polastri | Global Value and Access Head, Nephrology Franchise | Kyowa Kirin » speaking at World EPA Congress

Sonia Pulido Sánchez, Co-Chair of the Subgroup for Joint Scientific Consultations of the HTACG, AEMPS

Sonia Pulido Sánchez | Co-Chair of the Subgroup for Joint Scientific Consultations of the HTACG | AEMPS » speaking at World EPA Congress

Jennifer Quinn, Senior Director, Head of Market Access, Europe and International, Jazz Pharmaceuticals

Jennifer Quinn | Senior Director, Head of Market Access, Europe and International | Jazz Pharmaceuticals » speaking at World EPA Congress

Marco Rauland, Vice President, Market Access, Strategy, Pricing and Analytics, Merck KGaA

Marco Rauland | Vice President, Market Access, Strategy, Pricing and Analytics | Merck KGaA » speaking at World EPA Congress

Magdalena Rdzanek, Consultant, AOTMiT

Magdalena Rdzanek | Consultant | AOTMiT » speaking at World EPA Congress

Adriana Robayo, Executive Director, Instituto de Evaluaci�n Tecnol�gica en Salud (IETS)

Adriana Robayo | Executive Director | Instituto de Evaluaci�n Tecnol�gica en Salud (IETS) » speaking at World EPA Congress

Sandra Rose, Head of Market Access & Public Affairs, Chiesi

Sandra Rose | Head of Market Access & Public Affairs | Chiesi » speaking at World EPA Congress

Mihai Rotaru, Director, Market Access, EFPIA

Mihai Rotaru | Director, Market Access | EFPIA » speaking at World EPA Congress

Charlotte Roy, Life Sciences Policy and Influencing Manager, The Muscular Dystrophy U.K.

Charlotte Roy | Life Sciences Policy and Influencing Manager | The Muscular Dystrophy U.K. » speaking at World EPA Congress

Alberto Rubio, VP, Executive Partner, ProductLife Group

Alberto Rubio | VP, Executive Partner | ProductLife Group » speaking at World EPA Congress

Sandrine Ruiz, Senior Director, Market Access, Pricing, HEOR & RWE, Immunocore Ltd

Sandrine Ruiz | Senior Director, Market Access, Pricing, HEOR & RWE | Immunocore Ltd » speaking at World EPA Congress

Stephanie Said, Coordination EU HTA Medicinal Products and Chair of the HTA JSC Subgroup, G-BA

Noem Sain, Director, EU Market Access, UCB Pharma

Noem Sain | Director, EU Market Access | UCB Pharma » speaking at World EPA Congress

Steve Sandor, Vice President, Market Access, Trade and Government Affairs, Paratek Pharmaceuticals , Inc.

Steve Sandor | Vice President, Market Access, Trade and Government Affairs | Paratek Pharmaceuticals , Inc. » speaking at World EPA Congress

Natalia Scherff, Leadership Coach, INSEAD, ICF PCC, Coach Scherff

Ayman Semaan, Head of Market Access & Pricing, Biologix

Hans Severens, Independent HTA/MA Expert, Severens HTA consultancy

Steve Sharp, Scientific Advisor, National Institute for Health and Care Excellence

Steve Sharp | Scientific Advisor | National Institute for Health and Care Excellence » speaking at World EPA Congress

Kersten Sharrock, Global Head Integrated Patient Engagement, Sanofi

Kersten Sharrock | Global Head Integrated Patient Engagement | Sanofi » speaking at World EPA Congress

Barinder Singh, Founder & Director, Pharmacoevidence

Barinder Singh | Founder & Director | Pharmacoevidence » speaking at World EPA Congress

Marta Slomka, Vice Director, Agency for Health Technology Assessment and Tariff System

Jiri Smejkal, Access & Value Head PDT, Takeda

Joshua Smeltzer, Head of Pricing & Contracting, Market Access Germany, Ipsen Pharma GmbH

Joshua Smeltzer | Head of Pricing & Contracting, Market Access Germany | Ipsen Pharma GmbH » speaking at World EPA Congress

Raphael Sonabend-Friend, Associate Director, National Institute for Health and Care Excellence

Raphael Sonabend-Friend | Associate Director | National Institute for Health and Care Excellence » speaking at World EPA Congress

Manoj Sood, Commercial Access Director, Independent Market Access Expert

Manoj Sood | Commercial Access Director | Independent Market Access Expert » speaking at World EPA Congress

Andrew Spiegel, CEO, Global Colon Cancer Association

Andrew Spiegel | CEO | Global Colon Cancer Association » speaking at World EPA Congress

Michal Stanak, General Manager, Beneluxa Initative

Lotte Steuten, Deputy CEO, Office of Health Economics

Lotte Steuten | Deputy CEO | Office of Health Economics » speaking at World EPA Congress

Valentina Strammiello, Interim Executive Director, European Patients' Forum

Valentina Strammiello | Interim Executive Director | European Patients' Forum » speaking at World EPA Congress

Jan Swiderski, Head of Government Affairs & Policy, KYOWA KIRIN International

Jan Swiderski | Head of Government Affairs & Policy | KYOWA KIRIN International » speaking at World EPA Congress

Neeta Tandon, Vice President, Value & Evidence Scientific Engagement, Johnson & Johnson Innovation

Neeta Tandon | Vice President, Value & Evidence Scientific Engagement | Johnson & Johnson Innovation » speaking at World EPA Congress

Siguroli Teitsson, Director, GHEOR Economic & Predictive Modeling, Bristol Myers Squibb

Siguroli Teitsson | Director, GHEOR Economic & Predictive Modeling | Bristol Myers Squibb » speaking at World EPA Congress

Elena Tricca, Vice President, Global Market Access and Pricing, BioPharmaceuticals, AstraZeneca

Elena Tricca | Vice President, Global Market Access and Pricing, BioPharmaceuticals | AstraZeneca » speaking at World EPA Congress

Sheela Upadhyaya, Rare Disease Consultant, Rarely Ordinary

Sheela Upadhyaya | Rare Disease Consultant | Rarely Ordinary » speaking at World EPA Congress

Allister Upton, Value & Access Manager, Novo Nordisk

Allister Upton | Value & Access Manager | Novo Nordisk » speaking at World EPA Congress

Caroline van der Meijden, di, iMTA

Caroline van der Meijden | di | iMTA » speaking at World EPA Congress

Kevin van Dooren, Vice President HEOR & Market Access, Propharma group

Goedele Van Haasteren, Staff Member, Federal Office of Public Health, Switzerland

Goedele Van Haasteren | Staff Member | Federal Office of Public Health, Switzerland » speaking at World EPA Congress

Floortje van Nooten, Head of Market Access EU, Shionogi BV

Floortje van Nooten | Head of Market Access EU | Shionogi BV » speaking at World EPA Congress

Oliver van Zon, VP Market Access Europe, Crinetics Pharmaceuticals

Oliver van Zon | VP Market Access Europe | Crinetics Pharmaceuticals » speaking at World EPA Congress

Yvette Venable, Head of EU/CAN Maket Access, BBU, AstraZeneca

Annemiek Verkamman, Managing Director, hollandbio

Annemiek Verkamman | Managing Director | hollandbio » speaking at World EPA Congress

Anna Vicere, Director, Access Policy & Public Affairs, Vaccines Europe

Anna Vicere | Director, Access Policy & Public Affairs | Vaccines Europe » speaking at World EPA Congress

Rosa Maria Vivanco Hidalgo, Head of Health Technology Assessment, AQuAS Gencat

Rosa Maria Vivanco Hidalgo | Head of Health Technology Assessment | AQuAS Gencat » speaking at World EPA Congress

Yulia Voloshchuk, Head of Market Access, Innovative Medicine Europe, Teva

Yulia Voloshchuk | Head of Market Access, Innovative Medicine Europe | Teva » speaking at World EPA Congress

Reg Waldeck, Vice President, Head Global Market Access, Bayer

Tina Wang, Director, HTA programme and Strategic Partnership, Center for Innovation in Regulatory Science

Tina Wang | Director, HTA programme and Strategic Partnership | Center for Innovation in Regulatory Science » speaking at World EPA Congress

Billy West, Equitable Access Lead, Wellcome Trust

Billy West | Equitable Access Lead | Wellcome Trust » speaking at World EPA Congress

Anne Willemsen, Chair JCA Subgroup, Zorginstituut Nederland

Anne Willemsen | Chair JCA Subgroup | Zorginstituut Nederland » speaking at World EPA Congress

Tonya Winders, President, gaapp.org

Keir Woods, Vice President, Global Value Demonstration, Market Access & Pricing (GVAP), Oncology, Merck Group

Keir Woods | Vice President, Global Value Demonstration, Market Access & Pricing (GVAP), Oncology | Merck Group » speaking at World EPA Congress

Get Involved 
 

Sponsorship & Exhibition Sales


Oliver Hersey-Swan
oliver.hersey-swan@terrapinn.com

Speaking Opportunities


Isla Sutherland
isla.sutherland@terrapinn.com
 

Marketing Opportunities


Hidy Lee
hidy.lee@terrapinn.com